Focal Segmental Glomerulosclerosis Clinical Trial

Focal Segmental Glomerulosclerosis Clinical Trial

NCT03493685 | Phase 3 | Interventional

Sponsored by

Retrophin, Inc.

Have you or a loved one been diagnosed with focal segmental glomerulosclerosis? You may be eligible to participate in a focal segmental glomerulosclerosis clinical trial.

  • Currently Recruiting
  • Male & Female Participants
  • 8-75 years old

*This study is looking to recruit 300 participants

To determine the long-term nephroprotective potential of treatment with sparsentan as compared to an angiotensin receptor blocker in patients with primary focal segmental glomerulosclerosis (FSGS).


Available Locations

Study Details


We're not around right now. But you can send us an email and we'll get back to you, asap.


©2017 My City Med. All Rights Reserved.


Log in with your credentials


Forgot your details?


Create Account